%Patient histology, surgical stage, tumor uptake,and Ki-67 scores
This Table summarizes the following parameters measured for the 39 patients evaluated in this study: histological subtype and tumor differentiation, surgical stage, tumor diameter, Ki-67 score,uncorrected tumor maxSUV, PV corr maxSUV, and gluc-PV corr maxSUV. For clarity, the values for the BSA definition of the SUV are not included.
Patient no. . | Histology . | Stage . | CT diam.a (cm) . | Ki-67 . | maxSUV . | PV corr maxSUV . | gluc-PV corr maxSUV . |
---|---|---|---|---|---|---|---|
1 | pd adenoca | IIIA | 4.00 | 20 | 13.81 | 13.81 | 12.29 |
2 | md adenoca | IB | 1.10 | 40 | 2.82 | 7.67 | 7.59 |
3 | md SCCa | IB | 2.33 | 70 | 22.26 | 24.45 | 17.28 |
4 | wd BAC | IA | 1.00 | 5 | 2.92 | 9.19 | 8.85 |
5 | md adenoca | IIB | 3.20 | 20 | 7.86 | 7.86 | 7.94 |
6 | pd SCCa | IIB | 4.03 | 60 | 15.05 | 15.05 | 14.95 |
7 | pd adenocab | IB | 5.33 | 30 | 11.18 | 11.18 | 12.33 |
8 | pd SCCa | IB | 2.50 | 30 | 6.42 | 6.78 | 4.54 |
9 | pd adenoca | IA | 1.03 | 30 | 7.00 | 24.01 | 22.25 |
10 | pd large cell | IA | 1.77 | 90 | 10.88 | 15.95 | 11.01 |
11 | wd BAC | IA | 1.13 | 5 | 3.21 | 7.27 | 7.27 |
12 | pd carcinosarc | IB | 4.33 | 50 | 14.56 | 14.56 | 11.36 |
13 | pd SCCa | IA | 1.20 | 90 | 7.77 | 19.99 | 18.12 |
14 | pd large cell | IIIB | 3.67 | 50 | 14.87 | 14.87 | 14.28 |
15 | md adenoca | IA | 0.70 | 70 | 2.67 | 17.14 | 16.37 |
16 | md adenoca | IB | 1.00 | 30 | 2.39 | 7.79 | 6.05 |
17 | md adenoca | IA | 2.00 | 80 | 10.03 | 12.67 | 9.80 |
18 | wd BAC | IB | 5.00 | 2.5 | 3.44 | 3.44 | 2.61 |
19 | md adenoca | IA | 1.73 | 40 | 3.85 | 5.68 | 5.68 |
20 | md adenoca | IIB | 3.40 | 30 | 7.70 | 7.70 | 6.80 |
21 | wd BAC | IB | 2.50 | 2.5 | 4.01 | 4.22 | 4.79 |
22 | pd adenoca | IIB | 1.50 | 50 | 19.92 | 37.24 | 33.39 |
23 | md adenoca | cIIIA | 5.00 | 70 | 12.64 | 12.64 | 9.23 |
24 | pd adenoca | IV | 4.83 | 40 | 9.17 | 9.17 | 8.19 |
25 | pd large cell | IV | 4.33 | 90 | 11.28 | 11.28 | 10.56 |
26 | md SCCa | IB | 3.83 | 20 | 9.27 | 9.27 | 9.02 |
27 | wd adenoca | IB | 2.73 | 5 | 3.51 | 3.54 | 3.22 |
28 | md adenoca | IIIA | 2.60 | 30 | 8.09 | 8.39 | 6.99 |
29 | wd BAC | IB | 3.70 | 2.5 | 0.55 | 0.55 | 0.59 |
30 | pd large cell | IV | 4.83 | 60 | 15.03 | 15.03 | 12.37 |
31 | md SCCa | IIIB | 3.10 | 50 | 10.68 | 10.68 | 13.03 |
32 | pd large cell | IA | 1.30 | 70 | 7.51 | 16.69 | 14.69 |
33 | pd SCCa | IB | 4.27 | 60 | 12.47 | 12.47 | 9.81 |
34 | pd adenoca | IB | 4.77 | 60 | 9.92 | 9.92 | 9.09 |
35 | pd adenosquam | IA | 1.17 | 70 | 4.60 | 11.80 | 12.74 |
36 | md SCCa | IB | 3.33 | 80 | 9.71 | 9.71 | 8.44 |
37 | md adenoca | IA | 2.17 | 10 | 4.94 | 5.60 | 4.53 |
38 | pd large cell | IIIB | 6.10 | 90 | 15.86 | 15.86 | 13.16 |
39 | wd BAC | IB | 1.80 | 10 | 1.30 | 1.76 | 1.04 |
Patient no. . | Histology . | Stage . | CT diam.a (cm) . | Ki-67 . | maxSUV . | PV corr maxSUV . | gluc-PV corr maxSUV . |
---|---|---|---|---|---|---|---|
1 | pd adenoca | IIIA | 4.00 | 20 | 13.81 | 13.81 | 12.29 |
2 | md adenoca | IB | 1.10 | 40 | 2.82 | 7.67 | 7.59 |
3 | md SCCa | IB | 2.33 | 70 | 22.26 | 24.45 | 17.28 |
4 | wd BAC | IA | 1.00 | 5 | 2.92 | 9.19 | 8.85 |
5 | md adenoca | IIB | 3.20 | 20 | 7.86 | 7.86 | 7.94 |
6 | pd SCCa | IIB | 4.03 | 60 | 15.05 | 15.05 | 14.95 |
7 | pd adenocab | IB | 5.33 | 30 | 11.18 | 11.18 | 12.33 |
8 | pd SCCa | IB | 2.50 | 30 | 6.42 | 6.78 | 4.54 |
9 | pd adenoca | IA | 1.03 | 30 | 7.00 | 24.01 | 22.25 |
10 | pd large cell | IA | 1.77 | 90 | 10.88 | 15.95 | 11.01 |
11 | wd BAC | IA | 1.13 | 5 | 3.21 | 7.27 | 7.27 |
12 | pd carcinosarc | IB | 4.33 | 50 | 14.56 | 14.56 | 11.36 |
13 | pd SCCa | IA | 1.20 | 90 | 7.77 | 19.99 | 18.12 |
14 | pd large cell | IIIB | 3.67 | 50 | 14.87 | 14.87 | 14.28 |
15 | md adenoca | IA | 0.70 | 70 | 2.67 | 17.14 | 16.37 |
16 | md adenoca | IB | 1.00 | 30 | 2.39 | 7.79 | 6.05 |
17 | md adenoca | IA | 2.00 | 80 | 10.03 | 12.67 | 9.80 |
18 | wd BAC | IB | 5.00 | 2.5 | 3.44 | 3.44 | 2.61 |
19 | md adenoca | IA | 1.73 | 40 | 3.85 | 5.68 | 5.68 |
20 | md adenoca | IIB | 3.40 | 30 | 7.70 | 7.70 | 6.80 |
21 | wd BAC | IB | 2.50 | 2.5 | 4.01 | 4.22 | 4.79 |
22 | pd adenoca | IIB | 1.50 | 50 | 19.92 | 37.24 | 33.39 |
23 | md adenoca | cIIIA | 5.00 | 70 | 12.64 | 12.64 | 9.23 |
24 | pd adenoca | IV | 4.83 | 40 | 9.17 | 9.17 | 8.19 |
25 | pd large cell | IV | 4.33 | 90 | 11.28 | 11.28 | 10.56 |
26 | md SCCa | IB | 3.83 | 20 | 9.27 | 9.27 | 9.02 |
27 | wd adenoca | IB | 2.73 | 5 | 3.51 | 3.54 | 3.22 |
28 | md adenoca | IIIA | 2.60 | 30 | 8.09 | 8.39 | 6.99 |
29 | wd BAC | IB | 3.70 | 2.5 | 0.55 | 0.55 | 0.59 |
30 | pd large cell | IV | 4.83 | 60 | 15.03 | 15.03 | 12.37 |
31 | md SCCa | IIIB | 3.10 | 50 | 10.68 | 10.68 | 13.03 |
32 | pd large cell | IA | 1.30 | 70 | 7.51 | 16.69 | 14.69 |
33 | pd SCCa | IB | 4.27 | 60 | 12.47 | 12.47 | 9.81 |
34 | pd adenoca | IB | 4.77 | 60 | 9.92 | 9.92 | 9.09 |
35 | pd adenosquam | IA | 1.17 | 70 | 4.60 | 11.80 | 12.74 |
36 | md SCCa | IB | 3.33 | 80 | 9.71 | 9.71 | 8.44 |
37 | md adenoca | IA | 2.17 | 10 | 4.94 | 5.60 | 4.53 |
38 | pd large cell | IIIB | 6.10 | 90 | 15.86 | 15.86 | 13.16 |
39 | wd BAC | IB | 1.80 | 10 | 1.30 | 1.76 | 1.04 |
diam., diameter; wd,well-differentiated; md, moderately differentiated; pd, poorly differentiated; cIIIA, clinical stage IIIA (patient was not surgically staged after PET imaging); adenoca, adenocarcinoma; BAC,bronchoalveolar cell carcinoma (a subtype of adenoca); SCCa, squamous cell carcinoma; large cell, large cell carcinoma; carcinosarc,carcinosarcoma (a large cell carcinoma subtype).
Clara cell type adenocarcinoma.